_id
6915fed7bc934aba376b2886
Ticker
SRZN
Name
Surrozen Inc
Exchange
NASDAQ
Address
171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.surrozen.com
Description
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6 for the treatment of DME/wet AMD/uveitic macular edema; SZN-113 to treat Fuchs' endothelial corneal dystrophy and geographic atrophy; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
Last Close
23.81
Volume
70982
Current Price
24.59
Change
3.275934481310379
Last Updated
2025-12-04T13:32:42.037Z
Image
data:image/webp;base64,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
Ipo Date
2021-01-11T00:00:00.000Z
Market Cap
134999888
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.7916000000000001
Sentiment Sources
5
Rating
4.5
Target Price
36.6667
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
983000
Cost Of Revenue
-
Gross Profit
983000
Operating Expenses
11868000
Operating Income
-10885000
Interest Expense
-
Pretax Income
-71643000
Net Income
-71643000
Eps
-8.35876793839692
Dividends Per Share
-
Shares Outstanding
8571421
Income Tax Expense
-
EBITDA
-71582000
Operating Margin
-1107.3245167853509
Total Other Income Expense Net
-60758000
Cash
81335000
Short Term Investments
-
Receivables
2568000
Inventories
-
Total Current Assets
85860000
Property Plant Equipment
6589000
Total Assets
94046000
Payables
538000
Short Term Debt
1244000
Long Term Debt
-
Total Liabilities
117561000
Equity
-23515000
Depreciation
61000
Change In Working Capital
-355000
Cash From Operations
-9040000
Capital Expenditures
24000
Cash From Investing
-24000
Cash From Financing
9000
Net Change In Cash
-9055000
PE
-
PB
-8.962827556878588
ROE
304.6693599829896
ROA
-76.1786785190226
FCF
-9064000
Fcf Percent
-9.220752797558495
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
2.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2.5
Growth Investing Score
3
Momentum Investing Score
2.5
Net Net Investing Score
1.5
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
983000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
983000
Quarters > 0 > income Statement > operating Expenses
11868000
Quarters > 0 > income Statement > operating Income
-10885000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-71643000
Quarters > 0 > income Statement > net Income
-71643000
Quarters > 0 > income Statement > eps
-8.35876793839692
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
8571000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-71582000
Quarters > 0 > income Statement > operating Margin
-1107.3245167853509
Quarters > 0 > income Statement > total Other Income Expense Net
-60758000
Quarters > 0 > balance Sheet > cash
81335000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2568000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
85860000
Quarters > 0 > balance Sheet > property Plant Equipment
6589000
Quarters > 0 > balance Sheet > total Assets
94046000
Quarters > 0 > balance Sheet > payables
538000
Quarters > 0 > balance Sheet > short Term Debt
1244000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
117561000
Quarters > 0 > balance Sheet > equity
-23515000
Quarters > 0 > cash Flow > net Income
-71643000
Quarters > 0 > cash Flow > depreciation
61000
Quarters > 0 > cash Flow > change In Working Capital
-355000
Quarters > 0 > cash Flow > cash From Operations
-9040000
Quarters > 0 > cash Flow > capital Expenditures
24000
Quarters > 0 > cash Flow > cash From Investing
-24000
Quarters > 0 > cash Flow > cash From Financing
9000
Quarters > 0 > cash Flow > net Change In Cash
-9055000
Quarters > 0 > ratios > PE
-8.35876793839692
Quarters > 0 > ratios > PB
-8.962827556878588
Quarters > 0 > ratios > ROE
304.6693599829896
Quarters > 0 > ratios > ROA
-76.1786785190226
Quarters > 0 > ratios > FCF
-9064000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-9.220752797558495
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
983000
Quarters > 1 > income Statement > cost Of Revenue
137000
Quarters > 1 > income Statement > gross Profit
983000
Quarters > 1 > income Statement > operating Expenses
10000000
Quarters > 1 > income Statement > operating Income
-9017000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
39746000
Quarters > 1 > income Statement > net Income
39746000
Quarters > 1 > income Statement > eps
4.653553448073996
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
8541000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-8880000
Quarters > 1 > income Statement > operating Margin
-917.2939979654121
Quarters > 1 > income Statement > total Other Income Expense Net
48763000
Quarters > 1 > balance Sheet > cash
90390000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2569000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
94235000
Quarters > 1 > balance Sheet > property Plant Equipment
7076000
Quarters > 1 > balance Sheet > total Assets
102696000
Quarters > 1 > balance Sheet > payables
354000
Quarters > 1 > balance Sheet > short Term Debt
1198000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
55582000
Quarters > 1 > balance Sheet > equity
47114000
Quarters > 1 > cash Flow > net Income
39746000
Quarters > 1 > cash Flow > depreciation
137000
Quarters > 1 > cash Flow > change In Working Capital
529000
Quarters > 1 > cash Flow > cash From Operations
-6113000
Quarters > 1 > cash Flow > capital Expenditures
18000
Quarters > 1 > cash Flow > cash From Investing
-18000
Quarters > 1 > cash Flow > cash From Financing
-5124000
Quarters > 1 > cash Flow > net Change In Cash
-11255000
Quarters > 1 > ratios > PE
4.653553448073996
Quarters > 1 > ratios > PB
4.457766056798404
Quarters > 1 > ratios > ROE
84.36133633314938
Quarters > 1 > ratios > ROA
38.70257848406949
Quarters > 1 > ratios > FCF
-6131000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-6.237029501525941
Quarters > 1 > health Score
59
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
983000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
983000
Quarters > 2 > income Statement > operating Expenses
10534000
Quarters > 2 > income Statement > operating Income
-9551000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-26970000
Quarters > 2 > income Statement > net Income
-26970000
Quarters > 2 > income Statement > eps
-7.433847850055127
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3628000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-9257000
Quarters > 2 > income Statement > operating Margin
-971.617497456765
Quarters > 2 > income Statement > total Other Income Expense Net
-17419000
Quarters > 2 > balance Sheet > cash
101645000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
2632000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
106011000
Quarters > 2 > balance Sheet > property Plant Equipment
7645000
Quarters > 2 > balance Sheet > total Assets
114829000
Quarters > 2 > balance Sheet > payables
302000
Quarters > 2 > balance Sheet > short Term Debt
1190000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
109155000
Quarters > 2 > balance Sheet > equity
5674000
Quarters > 2 > cash Flow > net Income
-26970000
Quarters > 2 > cash Flow > depreciation
294000
Quarters > 2 > cash Flow > change In Working Capital
-1376000
Quarters > 2 > cash Flow > cash From Operations
-9279000
Quarters > 2 > cash Flow > capital Expenditures
27000
Quarters > 2 > cash Flow > cash From Investing
-27000
Quarters > 2 > cash Flow > cash From Financing
76386000
Quarters > 2 > cash Flow > net Change In Cash
67080000
Quarters > 2 > ratios > PE
-7.433847850055127
Quarters > 2 > ratios > PB
15.723038420867113
Quarters > 2 > ratios > ROE
-475.32604864293273
Quarters > 2 > ratios > ROA
-23.487098206898953
Quarters > 2 > ratios > FCF
-9306000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-9.466937945066125
Quarters > 2 > health Score
9
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
655000
Quarters > 3 > income Statement > cost Of Revenue
322000
Quarters > 3 > income Statement > gross Profit
655000
Quarters > 3 > income Statement > operating Expenses
9247000
Quarters > 3 > income Statement > operating Income
-8592000
Quarters > 3 > income Statement > interest Expense
1693000
Quarters > 3 > income Statement > pretax Income
-28039000
Quarters > 3 > income Statement > net Income
-28039000
Quarters > 3 > income Statement > eps
-9.559836345039209
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
2933000
Quarters > 3 > income Statement > income Tax Expense
-348724
Quarters > 3 > income Statement > EBITDA
-8270000
Quarters > 3 > income Statement > operating Margin
-1311.7557251908397
Quarters > 3 > income Statement > total Other Income Expense Net
-19447000
Quarters > 3 > balance Sheet > cash
34565000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
2541000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
38932000
Quarters > 3 > balance Sheet > property Plant Equipment
8363000
Quarters > 3 > balance Sheet > total Assets
48467000
Quarters > 3 > balance Sheet > payables
306000
Quarters > 3 > balance Sheet > short Term Debt
1829000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
69847000
Quarters > 3 > balance Sheet > equity
-21380000
Quarters > 3 > cash Flow > net Income
-28039000
Quarters > 3 > cash Flow > depreciation
322000
Quarters > 3 > cash Flow > change In Working Capital
10163000
Quarters > 3 > cash Flow > cash From Operations
3481000
Quarters > 3 > cash Flow > capital Expenditures
19000
Quarters > 3 > cash Flow > cash From Investing
-19000
Quarters > 3 > cash Flow > cash From Financing
91000
Quarters > 3 > cash Flow > net Change In Cash
3553000
Quarters > 3 > ratios > PE
-9.559836345039209
Quarters > 3 > ratios > PB
-3.3733615528531335
Quarters > 3 > ratios > ROE
131.14593077642655
Quarters > 3 > ratios > ROA
-57.8517341696412
Quarters > 3 > ratios > FCF
3462000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
5.2854961832061065
Quarters > 3 > health Score
50
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
10655000
Annuals > 0 > income Statement > cost Of Revenue
1442000
Annuals > 0 > income Statement > gross Profit
10655000
Annuals > 0 > income Statement > operating Expenses
36194000
Annuals > 0 > income Statement > operating Income
-25539000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-63564000
Annuals > 0 > income Statement > net Income
-63564000
Annuals > 0 > income Statement > eps
-21.67200818274804
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
2933000
Annuals > 0 > income Statement > income Tax Expense
-63564000
Annuals > 0 > income Statement > EBITDA
-24097000
Annuals > 0 > income Statement > operating Margin
-239.69028625058658
Annuals > 0 > income Statement > total Other Income Expense Net
-38025000
Annuals > 0 > balance Sheet > cash
34565000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
2541000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
38932000
Annuals > 0 > balance Sheet > property Plant Equipment
8363000
Annuals > 0 > balance Sheet > total Assets
48467000
Annuals > 0 > balance Sheet > payables
306000
Annuals > 0 > balance Sheet > short Term Debt
1829000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
69847000
Annuals > 0 > balance Sheet > equity
-21380000
Annuals > 0 > cash Flow > net Income
-63564000
Annuals > 0 > cash Flow > depreciation
1442000
Annuals > 0 > cash Flow > change In Working Capital
-836000
Annuals > 0 > cash Flow > cash From Operations
-17628000
Annuals > 0 > cash Flow > capital Expenditures
26000
Annuals > 0 > cash Flow > cash From Investing
-26000
Annuals > 0 > cash Flow > cash From Financing
16176000
Annuals > 0 > cash Flow > net Change In Cash
-1478000
Annuals > 0 > ratios > PE
-21.67200818274804
Annuals > 0 > ratios > PB
-2.160652478952292
Annuals > 0 > ratios > ROE
297.30589335827875
Annuals > 0 > ratios > ROA
-131.14902923638766
Annuals > 0 > ratios > FCF
-17654000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1.6568747067104646
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
12500000
Annuals > 1 > income Statement > cost Of Revenue
27230000
Annuals > 1 > income Statement > gross Profit
-27230000
Annuals > 1 > income Statement > operating Expenses
18550000
Annuals > 1 > income Statement > operating Income
-45780000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-43042000
Annuals > 1 > income Statement > net Income
-43042000
Annuals > 1 > income Statement > eps
-21.329049221530834
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
2017999
Annuals > 1 > income Statement > income Tax Expense
2752000
Annuals > 1 > income Statement > EBITDA
-41131000
Annuals > 1 > income Statement > operating Margin
-366.24
Annuals > 1 > income Statement > total Other Income Expense Net
2738000
Annuals > 1 > balance Sheet > cash
36043000
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
2152000
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
41132000
Annuals > 1 > balance Sheet > property Plant Equipment
3858000
Annuals > 1 > balance Sheet > total Assets
46080000
Annuals > 1 > balance Sheet > payables
525000
Annuals > 1 > balance Sheet > short Term Debt
2497000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
8145000
Annuals > 1 > balance Sheet > equity
37935000
Annuals > 1 > cash Flow > net Income
-43042000
Annuals > 1 > cash Flow > depreciation
1911000
Annuals > 1 > cash Flow > change In Working Capital
-3929000
Annuals > 1 > cash Flow > cash From Operations
-40363000
Annuals > 1 > cash Flow > capital Expenditures
398000
Annuals > 1 > cash Flow > cash From Investing
51723000
Annuals > 1 > cash Flow > cash From Financing
276000
Annuals > 1 > cash Flow > net Change In Cash
11636000
Annuals > 1 > ratios > PE
-21.329049221530834
Annuals > 1 > ratios > PB
0.8378406287069987
Annuals > 1 > ratios > ROE
-113.46250164755503
Annuals > 1 > ratios > ROA
-93.40711805555556
Annuals > 1 > ratios > FCF
-40761000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-3.26088
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
12500000
Annuals > 2 > income Statement > cost Of Revenue
3269000
Annuals > 2 > income Statement > gross Profit
12500000
Annuals > 2 > income Statement > operating Expenses
56839000
Annuals > 2 > income Statement > operating Income
-44339000
Annuals > 2 > income Statement > interest Expense
1955000
Annuals > 2 > income Statement > pretax Income
-36004000
Annuals > 2 > income Statement > net Income
-27669000
Annuals > 2 > income Statement > eps
-11.953089663508582
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
2314799
Annuals > 2 > income Statement > income Tax Expense
-8335000
Annuals > 2 > income Statement > EBITDA
-42384000
Annuals > 2 > income Statement > operating Margin
-354.712
Annuals > 2 > income Statement > total Other Income Expense Net
8335000
Annuals > 2 > balance Sheet > cash
24690000
Annuals > 2 > balance Sheet > short Term Investments
51148000
Annuals > 2 > balance Sheet > receivables
1978000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
81305000
Annuals > 2 > balance Sheet > property Plant Equipment
6898000
Annuals > 2 > balance Sheet > total Assets
89435000
Annuals > 2 > balance Sheet > payables
658000
Annuals > 2 > balance Sheet > short Term Debt
2226000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
13434000
Annuals > 2 > balance Sheet > equity
76001000
Annuals > 2 > cash Flow > net Income
-36004000
Annuals > 2 > cash Flow > depreciation
1955000
Annuals > 2 > cash Flow > change In Working Capital
-8418000
Annuals > 2 > cash Flow > cash From Operations
-44145000
Annuals > 2 > cash Flow > capital Expenditures
728000
Annuals > 2 > cash Flow > cash From Investing
38309000
Annuals > 2 > cash Flow > cash From Financing
-2565000
Annuals > 2 > cash Flow > net Change In Cash
-8401000
Annuals > 2 > ratios > PE
-11.953089663508582
Annuals > 2 > ratios > PB
0.47970532295627694
Annuals > 2 > ratios > ROE
-36.4060999197379
Annuals > 2 > ratios > ROA
-30.937552412366525
Annuals > 2 > ratios > FCF
-44873000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-3.58984
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
3297000
Annuals > 3 > income Statement > gross Profit
-3297000
Annuals > 3 > income Statement > operating Expenses
54391000
Annuals > 3 > income Statement > operating Income
-54391000
Annuals > 3 > income Statement > interest Expense
2066000
Annuals > 3 > income Statement > pretax Income
-54648000
Annuals > 3 > income Statement > net Income
-52510000
Annuals > 3 > income Statement > eps
-22.482176099961123
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
2335628
Annuals > 3 > income Statement > income Tax Expense
-2138000
Annuals > 3 > income Statement > EBITDA
-52325000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-257000
Annuals > 3 > balance Sheet > cash
33091000
Annuals > 3 > balance Sheet > short Term Investments
68760000
Annuals > 3 > balance Sheet > receivables
0
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
105189000
Annuals > 3 > balance Sheet > property Plant Equipment
9376000
Annuals > 3 > balance Sheet > total Assets
137174000
Annuals > 3 > balance Sheet > payables
2718000
Annuals > 3 > balance Sheet > short Term Debt
2193000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
27474000
Annuals > 3 > balance Sheet > equity
109700000
Annuals > 3 > cash Flow > net Income
-54648000
Annuals > 3 > cash Flow > depreciation
2066000
Annuals > 3 > cash Flow > change In Working Capital
-221000
Annuals > 3 > cash Flow > cash From Operations
-48813000
Annuals > 3 > cash Flow > capital Expenditures
1269000
Annuals > 3 > cash Flow > cash From Investing
-77708000
Annuals > 3 > cash Flow > cash From Financing
124630000
Annuals > 3 > cash Flow > net Change In Cash
-1891000
Annuals > 3 > ratios > PE
-22.482176099961123
Annuals > 3 > ratios > PB
0.33533401093892434
Annuals > 3 > ratios > ROE
-47.866909753874204
Annuals > 3 > ratios > ROA
-38.279848950967384
Annuals > 3 > ratios > FCF
-50082000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-8.35876793839692
Valuation > metrics > PB
-8.962827556878588
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
304.6693599829896
Profitability > metrics > ROA
-83.44164919636617
Profitability > metrics > Net Margin
-72.88199389623601
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-178.44262295081967
Risk > final Score
-684
Risk > verdict
High
Liquidity > metrics > Current Ratio
48.18181818181818
Liquidity > metrics > Quick Ratio
48.18181818181818
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
55.42233943201596
Prev Valuations > 1
20
Prev Valuations > 2
50
Prev Profitabilities > 0
100
Prev Profitabilities > 1
0
Prev Profitabilities > 2
40
Prev Risks > 0
29
Prev Risks > 1
4
Prev Risks > 2
10
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T01:25:38.435Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-10
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-3.6046
Earnings History > 0 > eps Estimate
-1.17
Earnings History > 0 > eps Difference
-2.4346
Earnings History > 0 > surprise Percent
-208.0855
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-08
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.85
Earnings History > 1 > eps Estimate
-1.07
Earnings History > 1 > eps Difference
1.92
Earnings History > 1 > surprise Percent
179.4393
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-09
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-7.43
Earnings History > 2 > eps Estimate
-1.09
Earnings History > 2 > eps Difference
-6.34
Earnings History > 2 > surprise Percent
-581.6514
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-9.09
Earnings History > 3 > eps Estimate
-2.7
Earnings History > 3 > eps Difference
-6.39
Earnings History > 3 > surprise Percent
-236.6667
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-06
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.44
Earnings History > 4 > eps Estimate
-2.77
Earnings History > 4 > eps Difference
2.33
Earnings History > 4 > surprise Percent
84.1155
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-07
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1.54
Earnings History > 5 > eps Estimate
-2.79
Earnings History > 5 > eps Difference
1.25
Earnings History > 5 > surprise Percent
44.8029
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-08
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-4.24
Earnings History > 6 > eps Estimate
-4.25
Earnings History > 6 > eps Difference
0.01
Earnings History > 6 > surprise Percent
0.2353
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-19
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-4.41
Earnings History > 7 > eps Estimate
-3
Earnings History > 7 > eps Difference
-1.41
Earnings History > 7 > surprise Percent
-47
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-08
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.34
Earnings History > 8 > eps Estimate
-0.29
Earnings History > 8 > eps Difference
-0.05
Earnings History > 8 > surprise Percent
-17.2414
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-09
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.31
Earnings History > 9 > eps Estimate
-0.41
Earnings History > 9 > eps Difference
0.1
Earnings History > 9 > surprise Percent
24.3902
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-10
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.48
Earnings History > 10 > eps Estimate
-0.37
Earnings History > 10 > eps Difference
-0.11
Earnings History > 10 > surprise Percent
-29.7297
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-22
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.03
Earnings History > 11 > eps Estimate
-0.43
Earnings History > 11 > eps Difference
0.4
Earnings History > 11 > surprise Percent
93.0233
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.38
Earnings History > 12 > eps Estimate
-0.43
Earnings History > 12 > eps Difference
0.05
Earnings History > 12 > surprise Percent
11.6279
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.4
Earnings History > 13 > eps Estimate
-0.46
Earnings History > 13 > eps Difference
0.06
Earnings History > 13 > surprise Percent
13.0435
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-11
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.23
Earnings History > 14 > eps Estimate
-0.5
Earnings History > 14 > eps Difference
0.27
Earnings History > 14 > surprise Percent
54
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.6
Earnings History > 15 > eps Estimate
-0.44
Earnings History > 15 > eps Difference
-0.16
Earnings History > 15 > surprise Percent
-36.3636
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-15
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.51
Earnings History > 16 > eps Estimate
-0.38
Earnings History > 16 > eps Difference
-0.13
Earnings History > 16 > surprise Percent
-34.2105
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-06
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.38
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-14
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.31
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-01-04
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6 for the treatment of DME/wet AMD/uveitic macular edema; SZN-113 to treat Fuchs' endothelial corneal dystrophy and geographic atrophy; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
Stock Price
$ 0.00
0% increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ASurrozen (NASDAQ:SRZN) Is In A Good Position To Deliver On Growth Plans 富途牛牛
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$36.6667
Analyst Picks
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 54.49% of the total shares of Surrozen Inc
1.
StemPoint Capital LP(8.0106%)
since
2025/06/30
2.
VR Adviser, LLC(7.3851%)
since
2025/06/30
3.
RA Capital Management, LLC(7.0315%)
since
2025/06/30
4.
5AM Venture Management, LLC(3.6171%)
since
2025/06/30
5.
Stonepine Capital Management Llc(3.5708%)
since
2025/06/30
6.
Vivo Capital, LLC(3.0337%)
since
2025/06/30
7.
Samsara BioCapital, LLC(2.8167%)
since
2025/06/30
8.
Nantahala Capital Management, LLC(2.6782%)
since
2025/06/30
9.
Vanguard Group Inc(2.5547%)
since
2025/06/30
10.
Longwood Capital Partners LLC(1.9836%)
since
2025/06/30
11.
BRAIDWELL LP(1.6335%)
since
2025/06/30
12.
Regents Of The University Of California(1.5543%)
since
2025/06/30
13.
Vanguard Total Stock Mkt Idx Inv(1.1854%)
since
2025/07/31
14.
Adage Capital Partners Gp LLC(1.0344%)
since
2025/06/30
15.
Euclidean Capital LLC(1.0232%)
since
2025/06/30
16.
Vanguard Institutional Extnd Mkt Idx Tr(0.8769%)
since
2025/07/31
17.
Driehaus Capital Management LLC(0.7884%)
since
2025/06/30
18.
Armistice Capital, LLC(0.7001%)
since
2025/06/30
19.
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)(0.6432%)
since
2025/06/30
20.
Board of Ttees Leland Stanford Jr Univ(0.6083%)
since
2025/06/30
21.
Trustees Of Columbia University In The City Of New York(0.5593%)
since
2025/06/30
22.
Morgan Stanley - Brokerage Accounts(0.4056%)
since
2025/06/30
23.
iShares Micro-Cap ETF(0.1563%)
since
2025/08/31
24.
Fidelity Extended Market Index(0.1435%)
since
2025/07/31
25.
Fidelity Series Total Market Index(0.1008%)
since
2025/07/31
26.
Vanguard Instl Ttl Stk Mkt Idx InstlPls(0.062%)
since
2025/07/31
27.
Fidelity Total Market Index(0.0541%)
since
2025/07/31
28.
Spartan Total Market Index Pool G(0.0413%)
since
2025/07/31
29.
NT Ext Equity Mkt Idx Fd - L(0.038%)
since
2025/06/30
30.
Northern Trust Extended Eq Market Idx(0.038%)
since
2025/06/30
31.
Spartan Extended Market Index Pool F(0.0326%)
since
2025/07/31
32.
Fidelity Nasdaq Composite Index(0.0323%)
since
2025/07/31
33.
Extended Equity Market Fund K(0.0238%)
since
2025/06/30
34.
NT Ext Equity Mkt Idx Fd - NL(0.0141%)
since
2025/06/30
35.
1290 VT Micro Cap K(0.0132%)
since
2025/07/31
36.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0109%)
since
2025/06/30
37.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0107%)
since
2025/06/30
38.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0091%)
since
2024/12/31
39.
State St US Extended Mkt Indx NL Cl C(0.0071%)
since
2025/08/31
40.
Vanguard U.S. Eq Idx £ Acc(0.005%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-3.6046
EPS Estimate
-1.17
EPS Difference
-2.4346
Surprise Percent
-208.0855%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.